The high contribution of GRHL2 is likely to reflect the cellular history of ChRCC, as well as FOXI1 and KIT, as GRHL2 has been characterised as a distal nephron molecule36–38. The gene discussed is FOXI1; the disease is chromophobe renal cell carcinoma.